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Background/Aims  :  Legal  pulmonary  disability  in  Korea  is  decided  for  chronic  respiratory  patients  who  have  been 
diagnosed for a year or more, and the patients haven't gotten better after more than 2 months of sufficient treatment 
and  they  have  shown  no  change  in  their  pulmonary  function  within  the  two  years  after  their  original  diagnosis.  The 
purpose of this study was to investigate the clinical features and progress of those patients who have been diagnosed 
as  having  pulmonary  disability.
Methods  :  We  reviewed  retrospectively  the  medical  records  of  the  patients  who  had  been  decided  as  having 
pulmonary disability at a tertiary university hospital from 2003 to 2004, and these patients could be followed up for more 
than  6  months.
Results : The number of enrolled patients was 118 (male : female = 95 : 23) and their mean age was 60±10 years. 
Their  major  underlying  diseases  were  chronic  obstructive  pulmonary  disease  (n=45,  38%),  tuberculous  destroyed  lung 
(n=29, 25%), and bronchi al asthma ( n=27, 23%). Of  them, the number of patients with a class 1 pulmonary disabi lity 
were 24 (20%), there were 28 class 2 patients (24%) and 66 class 3 patients (56%). The FEV1 coul d be f ol lowed up 
for  42  of  these  patients,  of  whom  20  patients  showed  no  change  or  a  decrease  in  their  FEV1  but  22  showed  an 
increased  FEV1. Especially,  some of  them  showed the  increase  of  their FEV1 of 10% or more, and the 50% of them 
were patients with bronchial asthma. During the follow-up period, 6 patients died; 3 were class 1, 1 was class 2 and 
2  w e r e  c l a s s  3 .  F i v e  o f  t h e s e  p a t i e n t s  d i e d  o f  t h e i r  u n d e r l y i n g  pulmonary  diseases  or  combined  pneumonia.
Conclusions  :  It  is  necessary  to  decide  the  pulmonary  disability  after  sufficient  treatment  and  to  perform  periodic 
follow-up testing even after the disability decision for confirming that the disability is stable and also to adjust the class 
of the disability. Further studies are needed to observe the clinical progress and prognosis of patients with pulmonary 
disability  by  performing  long-term  follow-up  for  a  large  number  of  patients.
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INTRODUCTION
Legal  pulmonary  disability  is  a  newly  registered  disability  in 
Korea  according  to  the  Handicapped-person  Welfare  Law  that 
was revised and enacted on July 1, 2003. It is confined to those 
people with a chronic, severe respiratory disorder that creates a 
restriction  or  a  lack  of  ability  to  perform  an  activity.Sun  Young  Kyung,  et  al  :  Clinical  findings  of  legal  pulmonary  disable  patients  in  Korea 73
  In  1980,  the  World  Health  Organization  (WHO)  announced 
'Three international classifications of impairments, disabilities and 
handicaps  (ICIDH)',  which  defined  impairment  as  any  loss  or 
abnormality  of  psychological,  physiological  or  anatomical 
structure  or  function.  The  disability  is  any  restriction  or  lack  of 
ability that is caused by an impaired ability to perform an activity 
in  the  manner  or  within  the  range  considered  normal  for  a 
h u m a n  b e i n g ,  a n d  a  h a n d i c a p  i s  a  d i s a d v a n t a g e  f o r  a  g i v e n  
individual that caused by an impairment or a disability that limits 
o r  p r e v e n t s  t h e  f u l f i l l m e n t  o f  a  r o l e  t h a t  i s  n o r m a l  f o r  t h a t  
individual
1).
Respiratory  impairment  can  be  objectively  measured  through 
several  tests  such  as  spirometry,  measuring  the  carbon 
monoxide  diffusing  capacity  (DLco),  the  arterial  blood  gas 
analysis  (ABGA)  and  the  pulmonary  exercise  test.  Some 
additional  tests  may  be  required  according  to  the  underlying 
diseases.  For  example,  for  the  patient  with  bronchial  asthma,  a 
methacholine  bronchoprovocation  test  or  a  bronchodilator 
response  test  is  necessary
2).
The  American  thoracic  Society  (ATS)  has  defined  impairment 
as a purely a medical condition, whereas disability indicates the 
total effect of impairment on a patient's life. All this is affected by 
such  diverse  factors  as  age,  gender,  education,  the  economic 
and  social  environment  and  the  energy  requirements  of  an 
occupation. This definition can be said to include the handicaps 
suggested  by  WHO
2-4).
F o r  t h e  p u l m o n a r y  d i s a b i l i t y ,  t h e  A T S  h a s  a n n o u n c e d  t h e  
diagnostic  criteria  of  the  disability  based  on  the  pulmonary 
function  test  (PFT)  in  1982  and  1986
3-5).  Moreover,  the  criteria 
suggested  by  the  American  Medical  Association  in  2001  were 
also  used
6).
In  Korea,  the  diagnostic  criteria  are  specified  in  the 
Handicapped-person Welfare Law enacted in 2003. A pulmonary 
disability can be diagnosed when the duration of the disease is 
more  than  one  year  and  the  impairment  of  the  pulmonary 
function is fixed even after 2 or more months of treatment, and 
there is a decrease of the forced expiratory volume for 1 second 
(FEV1)  o n  t h e  P F T  o r  t h e r e  i s  h y p o x e m i a  o n  t h e  A B G A  a t  a  
resting  state,  as  well  as  dyspnea  is  present.  The  grade  of 
pulmonary  disability  can  be  decided  into  three  classes.
Only two indices, that is, the FEV1 and the partial pressure of 
oxygen in arterial blood (PaO2) , are used to evaluate pulmonary 
disability in Korea. However, there is no report on what kinds of 
pulmonary  diseases  could  be  determined  to  be  pulmonary 
disability with using these two indices, what their clinical features 
are  and  how  the  progress  of  disease  and  the  prognosis  would 
go  according  to  the  three  classes  of  pulmonary  disability.  The 
objectives  of  this  study  were  to  investigate  the  clinical  features 
and  progress  of  those  patients  who  have  been  diagnosed  with 
pulmonary  disability  in  our  hospital  and  they  could  be  followed 
u p  f o r  mo r e  t h a n  6  mo n t h s .
MATERIALS AND METHODS
The  medical  records  and  radiologic  findings  were  analyzed 
retrospectively  for  the  patients  who  had  been  diagnosed  with 
respiratory disability at Gachon University Gil medical center from 
July  2003  to  October  2004  and  they  could  be  followed  up  for 
more  than  6  months.
The  decision  for  diagnosing  pulmonary  disability  was  made 
according  to  the  implementing  regulation  of  the  Handicapped- 
p e r s o n  W e l f a r e  L a w  e n a c t e d  i n  2 0 0 3 .  T h e  s t a n d a r d s  a r e  a s  
follows:  the  disability  has  to  be  judged  by  pulmonary 
subspecialists, and more than a year had elapsed since the first 
diagnosis as related with the present state, and the disability is 
fixed  enough  to  show  no  improvement  even  after  continuous 
treatment of 2 months or more. The criteria for the diagnosis are 
(1) the pulmonary disability persists in spite of sufficient medical 
treatment, (2) before the disability decision is made, there should 
be  objective  testing  for  the  patient  through  ①  the  decision  on 
the degree of dyspnea, ② the chest radiography, ③ the PFT, ④ 
and  the  ABGA.  In  addition,  if  necessary,  computerized 
tomography  (CT)  of  the  chest,  bronchoscopy,  pulmonary 
exercise  testing,  ventilation-perfusion  scanning  of  the  lungs  and 
pulmonary  arteriography  should  be  done  for  a  more  accurate 
diagnosis  according  to  the  diseases,  (3)  of  the  repetitive  test 
results  for  more  than  2  months,  the  lowest  level  is  chosen  to 
represent  the  disease.
Through  the  above  standards,  the  grade  class  of  the 
pulmonary  disability  is  decided  as  follows: 
Pulmonary  Disability  Class  1  -  Those  who  feel  the  dyspnea, 
even  while  resting,  enough  to  receive  oxygen  treatment  due  to 
the  chronic  respiratory  insufficiency,  and  whose  FEV1 i s  l o w e r  
than 25% of the predicted value in the resting state or the PaO2 
without an oxygen supply is lower than 55 mmHg in the stable 
state  of  disease.
Pulmonary Disability Class 2 - Those who feel dyspnea even 
while  moving  in  the  house  due  to  chronic  respiratory 
i n s u f f i c i e n c y ,  a n d  w h o s e  F E V 1 i s  l o w e r  t h a n  3 0 %  o f  t h e  
predicted  value  in  the  resting  state  or  the  PaO2  without  an 
o x y g e n  s u p p l y  i s  l o w e r  t h a n  6 0  m m H g  i n  t h e  s t a b l e  s t a t e  o f  
disease.
Pulmonary Disability Class 3 - Those who feel dyspnea, even 
while  walking  on  flat  ground,  due  to  chronic  respiratory 
i n s u f f i c i e n c y ,  a n d  w h o s e  F E V 1 i s  l o w e r  t h a n  4 0 %  o f  t h e  
predicted  value  in  the  resting  state  or  the  PaO2  without  an 
o x y g e n  s u p p l y  i s  l o w e r  t h a n  6 5  m m H g  i n  t h e  s t a b l e  s t a t e  o f  
disease.
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Total
Disability
class  1
Disability
class  2
Disability
class  3
No.  of  patients  (%)
Male  :  female
Age,  years  (mean±SD)
BMI  (mean±SD)
Smoking  status
  C u r r e n t  s m o k e r
    Ex-smoker
  N o n - s m o k e r
PFT  at  diagnosis
  F V C ,  L / m i n  ( % )
  F E V 1,  L/min  (%)
  F E V 1/FVC,  %
 D L c o ,  %
A B G A  a t  r o o m  a i r
  S a O 2,  %
  P a O 2,  mmHg
118
95  :  23
60±10
21.5±3.2
9
30
35
1.7  (48.6)
0.85  (32.7)
50.9
67.7
94.7
80.0
24  (20%)
15  :  5
59±11
20.5±3.5
5
6
8
1.4  (37.9)
0.62  (23.2)
48.7
50.6
90.0
60.6
28  (24%)
20  :  3
60±9
20.5±3.7
5
5
9
1.6  (42.7)
0.73  (26.9)
48.8
55.8
95.9
92.8
66  (56%)
38  :  19
60±11
22.2±3.1
2
19
18
1.9  (54.7)
0.94  (37.5)
52.3
80.3
95.3
79.3
BMI,  body  mass  index;  PFT,  pulmonary  function  test;  FVC,  forced v i t a l  c a p a c i t y ;  F E V 1,  forced  expiratory  volume  for  1  second;  DLco, 
diffusing  capacity  of  carbon  monoxide;  ABGA,  arterial  blood  gas  analysis;  SaO2,  oxygen  saturation;  PaO2,  partial  pressure  of  oxygen 
in  arterial  blood
Table  1.  Clinical  characteristics  of  the  patients  with  legal  pulmonary  disability
Figure  1.  Underlying  pulmonary  diseases  of  the  patients  with  legal 
pulmonary  disability.  The  most  common  cause  of  the  pulmonary 
disa bility is C O P D  (38% ). C hronic obstructive a irwa y disea ses such as 
COPD,  TDL  (25%),  and  BA  (23%)  are  the  main  causes  of  pulmonary 
disability.
CEP,  chronic  eosinophilic  pneumonia;  Lung  Ca,  lung  cancer;  DILD, 
diffuse  interstitial  lung  disease;  BE,  bronchiectasis;  TDL,  tuberculous 
destroyed  lung;  BA,  bronchial  asthma;  COPD,  chronic  obstructive 
pulmonary  disease
the respiratory diseases and standards of the disability diagnosis 
a t  t h e  t i m e  o f  t h e  d i s a b i l i t y  d i a g n o s i s .  T h r o u g h  t h e  f o l l o w - u p  
investigation, the date of diagnosing the disability was examined 
along  with  the  patients'  hospitalization  and  death  records 
according  to  the  disability  class.  The  underlying  disease  of  the 
pulmonary  disability  was  based  on  the  diagnosis  by  the 
pulmonary subspecialists who had made the decision. The data 
is  presented  as  means  standard  deviations.  Chi-squared  tests 
were  performed  to  compare  the  categorical  variables  and  the 
orderly  data  was  evaluated  by  the  Mann-Whitney  U  test.  A  p 
value  below  0.05  was  considered  statistically  significant. 
Statistical  analyses  were  performed  using  SPSS  version  10.0 
(SPSS  Inc.,  Chicago,  Illinois,  USA).
RESULTS
Clinical  feature  of  pulmonary  disability
The  total  number  of  patients  who  had  been  diagnosed  with 
pulmonary  disability  was  158.  Among  them,  only  118  patients 
were followed up for more than 6 months. Their mean age was 
60±10  years,  and  the  number  of  males  and  females  was  95 
and  23,  respectively.  Of  the  74  patients  who  answered  the 
q u e s t i o n  i f  t h e y  h a d  s m o k e d ,  8 8 %  h a d  a  s m o k i n g  h i s t o r y  t h a t  
averaged 39±21 pack-years. For the pulmonary disability grade 
class, the class 1 patients were 20%, the class 2 patients were 
24%  and  the  class  3  patients  were  56%.  There  was  no 
significant  difference  for  gender,  age  and  the  smoking  history 
among  the  class  groups  (Table  1).
O f  t h e  d i a g n o s e d  d i s e a s e s  f o r  t h e  p u l m o n a r y  d i s a b i l i t y  
patients,  the  most  frequent  one  was  chronic  obstructive 
pulmonary disease (COPD)(n=45, 38%), and the next ones were 
tuberculous  destroyed  lung  (TDL)(n=29,  25%)  and  bronchial 
asthma  (BA)(n=27,  23%).  In  addition,  there  was  bronchiectasis 
(BE)(n=8,  6.7%),  interstitial  lung  disease  (n=5,  4%),  pneumo-
n e c t o my  ( n = 3 ,  2 . 5 % ) ,  a n d  l u n g  c a n c e r  ( n = 1 ,  0 . 8 % )  ( F i g u r e  1 ) .Sun  Young  Kyung,  et  al  :  Clinical  findings  of  legal  pulmonary  disable  patients  in  Korea 75
Total 
(n=118)
Class  1
(n=24) 
Class  2 
(n=28)
Class  3 
(n=66)
Initial  PFT
Initial  ABGA
Follow-up  PFT
Follow-up  ABGA
79  (67%)
5  (4%)
33  (28%)
1  (1%)
17  (70%)
1  (5%)
6  (25%)
0  (0%)
24  (86%)
1  (4%)
3  (10%)
0  (0%)
45  (68%)
0  (0%)
20  (30%)
1  (2%)
PFT,  pulmonary  function  test;  ABGA,  arterial  blood  gas  analysis
Table  2.  Diagnostic  tools  for  determining  legal  pulmonary  disability
FEV1 Increase No  change Decrease
Total  (n=42)
COPD
BA
TDL
BE
IPF
22  (52%)
10
7
3
1
1
7  (17%)
6
0
1
0
0
13  (31%)
7
3
3
0
0
FEV1,  forced  expiratory  volume  for  1  second;  COPD,  chronic  obstructive  lung  disease;  BA,  bronchial  asthma;  TDL,  tuberculous 
destroyed  lung;  BE,  bronchiectasis;  IPF,  idiopathic  pulmonary  fibrosis
Table  3.  FEV1  change  after  the  diagnosis  of  legal  pulmonary  disability
Class Sex/Age Pulmonary  disease Cause  of  death
S u r v i v a l  a f t e r  d i a g n o s e  
(months)
1
1
1
2
3
3
Male/71
Male/49
Male/56
Male/65
Male/68
Female/65
TDL
BA
COPD
IPF
TDL
TDL
TDL
Colon  cancer
COPD
Pneumonia
Pneumonia
TDL
2 
10
24
8
12
10
TDL,  tuberculous  destroyed  lung;  BA,  bronchial  asthma;  COPD,  chronic  obstructive  lung  disease;  IPF,  idiopathic  pulmonary  fibrosis
Table  4.  Mortality  of  the  patients  with  legal  pulmonary  disability
As  accompanying  diseases,  hypertension  (n=15,  12.7%)  was 
most frequent, and the next ones were diabetes mellitus (n=12, 
10.1%),  osteoporosis  (n=8,  6.7%),  and  ischemic  heart  disease 
(n=6,  5.1%).
D i a g n o s t i c  t e s t s  f o r  t h e  d e c i s i o n  o f  p u l m o n a r y  d i s a b i l i t y
All the patients who were diagnosed with pulmonary disability 
had  the  1st  PFT  performed,  and  26%  of  them  had  the  ABGA 
p e r f o r m e d .  A f t e r  2  m o n t h s ,  o n l y  2 8 %  o f  t h e  p a t i e n t s  h a d  t h e  
follow-up  PFT  performed  to  check  the  fixation  of  the  disease, 
and  13%  had  the  follow-up  ABGA  performed.  The  rest  of  the 
patients  (72%)  took  no  follow-up  tests. 
For 67% of the patients, the disability decision was made on 
the basis of 1st PFT, and 4% of the decisions were decided by 
the  1st  ABGA.  The  cases  for  which  the  decisions  were  not 
made  right  after  the  1st  PFT,  but  rather,  they  were  made 
according to the follow-up test after 2 months and according to 
the  disability  diagnosis  standards  were  just  29%  (PFT  28%, 
A B G A  1 % ) ( T a b l e  2 ) .
Follow-up  of  PFT  after  the  diagnosis  of  pulmonary  disability
After  the  decision  of  pulmonary  disability,  42  patients  were 
followed up with PFT. The average period for the follow-up PFT 
was  11.9  months  and  the  median  period  was  12  months.  Of 
them, 22 patients (52%) showed the increase of the FEV1 on the 
PFT; there were 10 patients with COPD, 7 with BA, 3 with TDL, 
1 with BE and 1 with idiopathic pulmonary fibrosis. Especially, 8 
of 22 patients (4 with BA, 2 with COPD, 1 with TDL and 1 with 
BE) showed a 10% or more increase in the FEV1. For 11 of the 
22  patients  with  an  increased  FEV1,  their  FEV1  was  more  than 
40%  of  the  predicted  value.  The  distribution  of  these  patients 
was  5  BE  patients,  4  COPD  patients,  1  TDL  patient  and  1 
idiopathic pulmonary fibrosis patient. The number of patients for 
w h o m  t h e i r  F E V 1  was  decreased  was  13  (31%);  there  were  7 The  Korean  Journal  of  Internal  Medicine  :  Vol.  23,  No.  2,  June  2008 76
C O P D  p a t i e n t s ,  3  B A  p a t i e n t s  a n d  3  T D L  p a t i e n t s  ( T a b l e  3 ) .
Clinical  progress  of  the  pulmonary  disability
D u r i n g  t h e  f o l l o w - u p  o b s e r v a t i o n  p e r i o d  ( a  m e d i a n  p e r i o d  o f  
1 6  m o n t h s )  a f t e r  t h e  p u l m o n a r y  d i s a b i l i t y  d i a g n o s i s ,  6  p a t i e n t s  
d i e d ;  t h e s e  w e r e  3  c l a s s  1  p a t i e n t s ,  1  c l a s s  2  p a t i e n t s  a n d  2  
class  3  patients.  The  cause  of  death  for  3  patients  was  the 
worsened  underlying  pulmonary  disease,  for  2  the  cause  of 
death was combined pneumonia and for 1 it was colon cancer 
(Table  4).
DISCUSSION
In  this  study,  the  clinical  characteristics  and  the  progress  of 
the patients who had been decided to have pulmonary disability 
were  observed  along  with  their  causal  underlying  diseases.  The 
most  important  diseases  that  caused  the  decreased  pulmonary 
function  were  chronic  airway  diseases  such  as  COPD  and  BA. 
The airway obstruction causes a decreased FEV1 and inevitably, 
a  respiratory  locomotive  disability,  and  it  can  cause  pulmonary 
disability.  For  the  cases  that  some  legal  claims  were  raised 
because  of  the  pulmonary  disability,  the  most  frequent  causal 
disease  was  COPD
7).  The  next  important  causal  diseases  were 
TDL  and  BE.  It  seems  that  this  is  because  of  the  high 
prevalence rate of tuberculosis among Koreans. TDL is a disease 
that  causes  severe  destruction  of  the  lung  parenchyma  due  to 
f a r  a d v a n c e d  t u b e r c u l o s i s ,  a n d  i t  u s u a l l y  r e s u l t s  i n  t h e  c h r o n i c 
airflow  obstruction
8).  I t  i s  k n o w n  t h a t  t h e  p a t i e n t s  w i t h  c h r o n i c  
airflow  obstruction  due  to  a  TDL  have  a  lower  FVC  and  FEV1 
and higher airway resistance
8). So, it can easily cause a disabling 
respiratory  condition.  In  addition,  some  restrictive  pattern 
pulmonary  disorders  such  as  interstitial  lung  disease  or  the 
post-pneumonectomy  state  could  decrease  the  FVC  and  FEV1 
and  so  they  might  cause  pulmonary  disability.
Pulmonary  disability  is  decided  when  the  pulmonary  function 
decline  due  to  chronic  pulmonary  disease  is  severe  enough  to 
interfere  with  the  walking  ability  of  the  patient.  Therefore,  an 
index  to  objectively  determine  the  locomotive  disability  of  the 
patient  is  necessary.  In  Korea,  the  FEV1 of  t he  PFT i s  t he  onl y 
index. It is based on that for the patients with the chronic airflow 
o b s t r u c t i o n ,  t h e  F E V 1  testing  is  non-invasive  and  simple,  and  it 
can  objectively  reflect  the  locomotive  disability  of  a  patient
6,9-12). 
But in other  countries, especially  according  to  the standards  of 
pulmonary  disability  presented  by  the  ATS  in  1982  and  1986, 
'severe  pulmonary  disability'  is  defined  when  the  FVC  on  the 
PFT is less than 50% of the predicted value, or the FEV1 is less 
than 40% of the predicted value, or the ratio of the FEV1/FVC is 
l e s s  t h a n  40 %,  or  t h e  D L c o  i s  l e s s  t h a n  4 0 % of  t h e  p r e d i c t e d 
value
3, 4). In addition to these, if more discrimination is necessary, 
a  pulmonary  exercise  test  or  the  ABGA  should  be  done  to 
objectify the decision of pulmonary disability. For the case of the 
reversible airway obstruction such as BA or a restrictive pattern 
pulmonary  disorder  such  as  interstitial  lung  disease,  another 
s t a n d a r d  w o u l d  b e  a p p l i e d  t o  d e c i d e  t h e  p u l m o n a r y  d i s a b i l i t y
5,
13).  I n  c a s e  o f  t h e  B A ,  t h e  A T S  r e c o m m e n d s  d e c i d i n g  o n  t h e  
pulmonary  disability  through  comprehensive  tests  on  the  peak 
e x p i r a t o r y  f l o w  r a t e  ( P E F R ) ,  t h e  P C 20  of  the  methacholine 
bronchoprovocation test or the required medicines to control the 
symptoms  of  BA,  as  well  as  the  FEV1
5).  For  the  case  of  the 
interstitial  lung  disease,  an  FVC  that's  less  than  50%  of  the 
predicted  value  and  a  DLco  less  than  40%  of  the  predicted 
value is considered as severe disability
13). In Korea, even though 
they  are  not  as  frequent  as  airway  obstructive  diseases,  other 
diseases that cause a restrictive pattern pulmonary disorder like 
interstitial lung diseases or lobectomy or pneumonectomy seem 
to need another pulmonary disability standard than just the FEV1.
The  most  frequently  used  test  to  diagnose  pulmonary 
disability  has  been  the  PFT.  This  is  because  determining  the 
FEV1 via PFT is very simple and noninvasive compared with the 
ABGA.  Before  the  implementing  regulation  of  the 
Handicapped-person  Welfare  Law,  the  patients  who  had  been 
treated  for  a  long  time  were  considered  to  be  fixed  in  their 
diseases  in  spite  of  their  medical  treatments,  and  their 
pulmonary disability used to be decided only with the PFT and 
without any follow-up test. Yet when the class of the pulmonary 
d i s a b i l i t y  w a s  d e c i d e d  o n l y  t h r o u g h  t h e  F E V 1,  there  were  many 
cases  that  the  PaO2  on  the  ABGA  of  the  patient  was  greater 
t ha n  t he  P a O 2  of  the  corresponding class.  Therefore,  when  the 
data  of  the  patients  who  were  decided  to  have  pulmonary 
disability is better accumulated in the future, it seems necessary 
to adjust the standard in order to match the PaO2 of the ABGA 
w i t h  t h e  F E V 1 o f  t h e  P F T .
In this study, 42 patients were followed up with PFT after the 
d i a g n o s i s  o f  t h e  p u l m o n a r y  d i s a b i l i t y .  O f  t h e m ,  2 2  p a t i e n t s  
showed  an  increased  FEV1  on  PFT.  When  deciding  on  the 
pulmonary  disability,  the  pulmonary  subspecilists  confirmed  that 
the PFT was similar to or decreased compared to the previous 
PFTs of the last 2 years or more. Because of the clause, "Of the 
repetitive test results for more than 2 months, the lowest level is 
used", it seems that there would be some variation of the FEV1 
w i t h i n  a  c l a s s .  H o w e v e r ,  t h e r e  w e r e  8  p a t i e n t s  w h o s e  F E V 1 
increased by 10% or more. Thus, if there is a FEV1 change over 
two  classes,  then  the  decision  on  the  class  of  the  pulmonary 
disability  may  have  been  erroneous.  Such  patients  should  be 
decided again, and a physician should make doubly sure not to 
make  any  errors.  Moreover,  for  the  11  of  22  patients  whose 
FEV1 was increased, their FEV1 increased up to more than 40% 
of the predicted value, which hardly allows them to be classified 
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patients  who  had  belonged  to  class  3  according  to  the 
regulation, "Of the repetitive test results for more than 2 months, 
the lowest level is used", their FEV1 increased a little bit later on. 
A n d ,  f o r  9  p a t i e n t s ,  t h e i r  F E V 1 i n c r e a s e d  b y  1 0 %  o r  m o r e  t o  
reach 40% of the predicted value. The disability class for these 
patients  should  also  be  decided  again. Thus,  it is  necessary  to 
carefully  diagnosis  the  patients'  disability  and  to  follow  up  their 
conditions.
Six  patients  died  during  the  clinical  progress.  Three  of  them 
h a d  b e l o n g e d  t o  t h e  c l a s s  1  o f  p u l m o n a r y  d i s a b i l i t y ,  a n d  5  o f  
them died of the worsened underlying pulmonary diseases or the 
combined  pneumonia.  Thus,  it  is  highly  probable  that  patients 
w i t h  t h e  p u l m o n a r y  d i s a b i l i t y  w i l l  d i e  o f  p u l m o n a r y  d i s e a s e s .  
Except their mortality, the other aspects of the patients such as 
their quality of life or the clinical features have not been analyzed 
for  each  class  of  pulmonary  disability.  In  the  future,  it  seems 
necessary to check the relationship of the quality of life with the 
disability class through a questionnaire on the quality of life or by 
comparison  of  the  clinical  features.
In  conclusion,  when  deciding  the  pulmonary  disability,  it  is 
necessary  to  decide  it  after  sufficient  treatment  has  been  done 
and to perform periodic follow-up testing even after the disability 
d e c i s i o n  f o r  c o n f i r m i n g  t h a t  t h e  d i s a b i l i t y  i s  s t a b l e  a n d  a l s o  to 
adjust the disability class. Moreover, additional diagnostic criteria 
are  needed  in  the  case  of  BA  or  interstitial  lung  diseases.  It  is 
necessary  to  gather  all  the  data  when  making  the  decision  on 
disability  by  performing  other  additional  tests. 
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